BiotechTube
Mercodia

Mercodia

Uppsala, Sweden· Est.
mercodia.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Mercodia is a long-established, privately-held provider of specialized immunoassays and bioanalytical services, focusing on cardiometabolic diseases. Its business model combines product sales of validated ELISA kits with a high-value service arm supporting preclinical and clinical drug development. With over 35 years of industry experience, a GLP-approved laboratory, and a strong reputation for data quality and customer support, Mercodia is a trusted partner for researchers and developers requiring reliable large-molecule bioanalysis.

MetabolicCardiovascular

Technology Platform

Expertise in immunoassay development and validation, primarily using ELISA and bead-based methods for the measurement of large molecules, biomarkers, and anti-drug antibodies. Platform supports both off-the-shelf kit manufacturing and custom bioanalytical service delivery.

Opportunities

The growing global prevalence of diabetes and obesity drives sustained demand for reliable research assays.
The rapid expansion of the biologics drug development pipeline creates increasing need for specialized, outsourced bioanalytical services in PK/PD and immunogenicity testing, a core Mercodia strength.

Risk Factors

Intense competition from larger, diversified life science tools and CRO companies could pressure margins and market share.
Technological shifts away from immunoassay-based methods, though gradual, pose a long-term risk.
Revenue concentration in the cardiometabolic sector makes the company vulnerable to downturns in that specific research and development funding.

Competitive Landscape

Mercodia competes in two segments: 1) In ELISA kits, against other specialized assay manufacturers (e.g., Alpco, Crystal Chem) and large reagent suppliers (e.g., R&D Systems, Thermo Fisher). 2) In bioanalytical services, it competes with global CROs (e.g., Labcorp, IQVIA, PPD) and niche bioanalytical CROs. Its differentiation lies in deep cardiometabolic expertise, a 'gold-standard' product reputation, and a client-centric service approach.

More companies in Sweden →